The prevalence of extra esophageal manifestations of gastroesophageal reflux disease in overweight and obese patients at King Abdulaziz University Hospital
Abstract
Objective:
This study aimed to determine the extraesophageal symptoms of gastroesophageal reflux disease (GERD) among overweight and obese patients.
Methods:
A cross-sectional study was performed at King Abdulaziz University Hospital (KAUH), Jeddah. Adult patients with a confirmed diagnosis of GERD and a body mass index (BMI) of 25 kg/m2 or higher were included. Using systematic random sampling, every fourth patient's file was selected, and participants were contacted through phone calls or text messages to complete a structured questionnaire. The tool assessed frequency and intensity of common extraesophageal symptoms using a 6-point Likert scale (0–5), where higher scores indicated greater frequency or severity.
Results:
A total of 434 participants were enrolled. Sleep disturbance was the most frequently reported daily symptom, affecting 13.1% of participants, with the highest mean of a non-validated questionnaire score (XQS) of 1.6 (1.8). Nausea was the second most frequent symptom (12.4%) with a mean score of 1.57 (1.73). Wheezing was the least reported (3.5%) with the lowest mean score of 0.31 (0.95). Regarding intensity, nausea had the highest severity prevalence (11.1%) and mean intensity score of 1.69 (1.74), followed by sleep disturbance at 8.5% with a mean intensity score of 1.62 (1.76).
Conclusion:
Extraesophageal manifestations were frequent yet under recognized in overweight and obese GERD patients. Sleep disturbance and nausea emerged as the most prominent…
How strong is the evidence?
Evidence Hub reads this as a cross-sectional, done in people. Its evidence level is 4 of 5 (Low · observational). Observational designs can show an association but not prove cause. Reported size: 434 participants or records.
Read the paper
Related studies
- Advantages and Disadvantages of Long-term Proton Pump Inhibitor Use
- Ivth brazilian consensus conference on helicobacter pylori infection
- A pSMAD/CDX2 complex is essential for the intestinalization of epithelial metaplasia
- S2k-Leitlinie Gastroösophageale Refluxkrankheit und eosinophile Ösophagitis der Deutschen Gesellschaft für Gastroenterologie, Verdauungs- und Stoffwechselkrankheiten (DGVS) – März 2023 – AWMF-Registernummer: 021–013
- Step-by-step management of refractory gastresophageal reflux disease
- Insights into Effects/Risks of Chronic Hypergastrinemia and Lifelong PPI Treatment in Man Based on Studies of Patients with Zollinger–Ellison Syndrome
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.